Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-02-06 @ 7:06 AM
Study NCT ID:
NCT02731560
Status:
COMPLETED
Last Update Posted:
2016-04-07
First Post:
2016-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS)
Sponsor:
Prof. Abid Z. Farooqi
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
ML25190
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None